Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 20/11/19961 min de lecture
Oral Dosage Form New Animal Drugs; Ivermectin With Pyrantel Pamoate
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Merck Research Laboratories, Division of Merck & Co., Inc., for chewable tablets containing ivermectin with pyrantel pamoate. The product is used to prevent canine heartworm disease and to treat and control ascarid and hookworm infections. The supplemental NADA provides for expanding the use for the treatment and control of an additional adult hookworm infection.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →